Prevalence of erythrovirus genotypes in the myocardium of patients with dilated cardiomyopathy
Parvovirus B19 (PVB19) is a member of the human erythrovirus family detected frequently in endomyocardial biopsies from patients with dilated cardiomyopathy. Human erythroviruses cluster into three genotypes 1-3 which share a high degree of homology between major structural proteins and may cause in...
Saved in:
| Published in | Journal of medical virology Vol. 80; no. 7; pp. 1243 - 1251 |
|---|---|
| Main Authors | , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
Hoboken
Wiley Subscription Services, Inc., A Wiley Company
01.07.2008
Wiley-Liss |
| Subjects | |
| Online Access | Get full text |
| ISSN | 0146-6615 1096-9071 |
| DOI | 10.1002/jmv.21187 |
Cover
| Abstract | Parvovirus B19 (PVB19) is a member of the human erythrovirus family detected frequently in endomyocardial biopsies from patients with dilated cardiomyopathy. Human erythroviruses cluster into three genotypes 1-3 which share a high degree of homology between major structural proteins and may cause indistinguishable infections clinically and serologically. In human cardiac tissue erythrovirus genotypes other than PVB19 have not yet been reported. Three hundred seventeen consecutive patients with symptomatic dilated cardiomyopathy (median left ventricular ejection fraction: 28.6%, range 5-45%) who underwent endomyocardial biopsy for the elucidation of the etiology, were analyzed using a new consensus PCR assay designed for the detection of the three erythrovirus genotype sequences. Endomyocardial biopsies of 151 (47.6%) patients were erythrovirus-positive. Genotype 1 specific sequences were detected in 43/151 (28.5%) of positive biopsy samples, whereas genotype 2-specific sequences so far considered rare in human disease and not yet been described in human heart tissue was identified in 108/151 (71.5%) of virus-positive endomyocardial biopsies with a preference in patients above 50 years of age. In spite of younger age, systolic left ventricular dysfunction of genotype 1-positive patients was significantly reduced as compared to genotype 2-positive patients (24.4 ± 10.4% vs. 31.0 ± 9.5%, P = 0.0001) at the initial presentation. The data show that two genetically distinct erythrovirus variants with a different age distribution are detectable in endomyocardial biopsies of patients with dilated cardiomyopathy. The erythrovirus genotype 2, not described previously in human heart tissue, is highly prevalent in the heart but the less prevalent genotype 1 is associated with more severe disturbed cardiac function. J. Med. Virol. 80: 1243-1251, 2008. |
|---|---|
| AbstractList | Parvovirus B19 (PVB19) is a member of the human erythrovirus family detected frequently in endomyocardial biopsies from patients with dilated cardiomyopathy. Human erythroviruses cluster into three genotypes 1-3 which share a high degree of homology between major structural proteins and may cause indistinguishable infections clinically and serologically. In human cardiac tissue erythrovirus genotypes other than PVB19 have not yet been reported. Three hundred seventeen consecutive patients with symptomatic dilated cardiomyopathy (median left ventricular ejection fraction: 28.6%, range 5-45%) who underwent endomyocardial biopsy for the elucidation of the etiology, were analyzed using a new consensus PCR assay designed for the detection of the three erythrovirus genotype sequences. Endomyocardial biopsies of 151 (47.6%) patients were erythrovirus-positive. Genotype 1 specific sequences were detected in 43/151 (28.5%) of positive biopsy samples, whereas genotype 2-specific sequences so far considered rare in human disease and not yet been described in human heart tissue was identified in 108/151 (71.5%) of virus-positive endomyocardial biopsies with a preference in patients above 50 years of age. In spite of younger age, systolic left ventricular dysfunction of genotype 1-positive patients was significantly reduced as compared to genotype 2-positive patients (24.4 ± 10.4% vs. 31.0 ± 9.5%, P = 0.0001) at the initial presentation. The data show that two genetically distinct erythrovirus variants with a different age distribution are detectable in endomyocardial biopsies of patients with dilated cardiomyopathy. The erythrovirus genotype 2, not described previously in human heart tissue, is highly prevalent in the heart but the less prevalent genotype 1 is associated with more severe disturbed cardiac function. J. Med. Virol. 80: 1243-1251, 2008. Parvovirus B19 (PVB19) is a member of the human erythrovirus family detected frequently in endomyocardial biopsies from patients with dilated cardiomyopathy. Human erythroviruses cluster into three genotypes 1-3 which share a high degree of homology between major structural proteins and may cause indistinguishable infections clinically and serologically. In human cardiac tissue erythrovirus genotypes other than PVB19 have not yet been reported. Three hundred seventeen consecutive patients with symptomatic dilated cardiomyopathy (median left ventricular ejection fraction: 28.6%, range 5-45%) who underwent endomyocardial biopsy for the elucidation of the etiology, were analyzed using a new consensus PCR assay designed for the detection of the three erythrovirus genotype sequences. Endomyocardial biopsies of 151 (47.6%) patients were erythrovirus-positive. Genotype 1 specific sequences were detected in 43/151 (28.5%) of positive biopsy samples, whereas genotype 2-specific sequences so far considered rare in human disease and not yet been described in human heart tissue was identified in 108/151 (71.5%) of virus-positive endomyocardial biopsies with a preference in patients above 50 years of age. In spite of younger age, systolic left ventricular dysfunction of genotype 1-positive patients was significantly reduced as compared to genotype 2-positive patients (24.4±10.4% vs. 31.0±9.5%, P=0.0001) at the initial presentation. The data show that two genetically distinct erythrovirus variants with a different age distribution are detectable in endomyocardial biopsies of patients with dilated cardiomyopathy. The erythrovirus genotype 2, not described previously in human heart tissue, is highly prevalent in the heart but the less prevalent genotype 1 is associated with more severe disturbed cardiac function. J. Med. Virol. 80: 1243-1251, 2008. Parvovirus B19 (PVB19) is a member of the human erythrovirus family detected frequently in endomyocardial biopsies from patients with dilated cardiomyopathy. Human erythroviruses cluster into three genotypes 1–3 which share a high degree of homology between major structural proteins and may cause indistinguishable infections clinically and serologically. In human cardiac tissue erythrovirus genotypes other than PVB19 have not yet been reported. Three hundred seventeen consecutive patients with symptomatic dilated cardiomyopathy (median left ventricular ejection fraction: 28.6%, range 5–45%) who underwent endomyocardial biopsy for the elucidation of the etiology, were analyzed using a new consensus PCR assay designed for the detection of the three erythrovirus genotype sequences. Endomyocardial biopsies of 151 (47.6%) patients were erythrovirus‐positive. Genotype 1 specific sequences were detected in 43/151 (28.5%) of positive biopsy samples, whereas genotype 2‐specific sequences so far considered rare in human disease and not yet been described in human heart tissue was identified in 108/151 (71.5%) of virus‐positive endomyocardial biopsies with a preference in patients above 50 years of age. In spite of younger age, systolic left ventricular dysfunction of genotype 1‐positive patients was significantly reduced as compared to genotype 2‐positive patients (24.4 ± 10.4% vs. 31.0 ± 9.5%, P = 0.0001) at the initial presentation. The data show that two genetically distinct erythrovirus variants with a different age distribution are detectable in endomyocardial biopsies of patients with dilated cardiomyopathy. The erythrovirus genotype 2, not described previously in human heart tissue, is highly prevalent in the heart but the less prevalent genotype 1 is associated with more severe disturbed cardiac function. J. Med. Virol. 80: 1243–1251, 2008. © 2008 Wiley‐Liss, Inc. Parvovirus B19 (PVB19) is a member of the human erythrovirus family detected frequently in endomyocardial biopsies from patients with dilated cardiomyopathy. Human erythroviruses cluster into three genotypes 1-3 which share a high degree of homology between major structural proteins and may cause indistinguishable infections clinically and serologically. In human cardiac tissue erythrovirus genotypes other than PVB19 have not yet been reported. Three hundred seventeen consecutive patients with symptomatic dilated cardiomyopathy (median left ventricular ejection fraction: 28.6%, range 5-45%) who underwent endomyocardial biopsy for the elucidation of the etiology, were analyzed using a new consensus PCR assay designed for the detection of the three erythrovirus genotype sequences. Endomyocardial biopsies of 151 (47.6%) patients were erythrovirus-positive. Genotype 1 specific sequences were detected in 43/151 (28.5%) of positive biopsy samples, whereas genotype 2-specific sequences so far considered rare in human disease and not yet been described in human heart tissue was identified in 108/151 (71.5%) of virus-positive endomyocardial biopsies with a preference in patients above 50 years of age. In spite of younger age, systolic left ventricular dysfunction of genotype 1-positive patients was significantly reduced as compared to genotype 2-positive patients (24.4+/-10.4% vs. 31.0+/-9.5%, P=0.0001) at the initial presentation. The data show that two genetically distinct erythrovirus variants with a different age distribution are detectable in endomyocardial biopsies of patients with dilated cardiomyopathy. The erythrovirus genotype 2, not described previously in human heart tissue, is highly prevalent in the heart but the less prevalent genotype 1 is associated with more severe disturbed cardiac function.Parvovirus B19 (PVB19) is a member of the human erythrovirus family detected frequently in endomyocardial biopsies from patients with dilated cardiomyopathy. Human erythroviruses cluster into three genotypes 1-3 which share a high degree of homology between major structural proteins and may cause indistinguishable infections clinically and serologically. In human cardiac tissue erythrovirus genotypes other than PVB19 have not yet been reported. Three hundred seventeen consecutive patients with symptomatic dilated cardiomyopathy (median left ventricular ejection fraction: 28.6%, range 5-45%) who underwent endomyocardial biopsy for the elucidation of the etiology, were analyzed using a new consensus PCR assay designed for the detection of the three erythrovirus genotype sequences. Endomyocardial biopsies of 151 (47.6%) patients were erythrovirus-positive. Genotype 1 specific sequences were detected in 43/151 (28.5%) of positive biopsy samples, whereas genotype 2-specific sequences so far considered rare in human disease and not yet been described in human heart tissue was identified in 108/151 (71.5%) of virus-positive endomyocardial biopsies with a preference in patients above 50 years of age. In spite of younger age, systolic left ventricular dysfunction of genotype 1-positive patients was significantly reduced as compared to genotype 2-positive patients (24.4+/-10.4% vs. 31.0+/-9.5%, P=0.0001) at the initial presentation. The data show that two genetically distinct erythrovirus variants with a different age distribution are detectable in endomyocardial biopsies of patients with dilated cardiomyopathy. The erythrovirus genotype 2, not described previously in human heart tissue, is highly prevalent in the heart but the less prevalent genotype 1 is associated with more severe disturbed cardiac function. Parvovirus B19 (PVB19) is a member of the human erythrovirus family detected frequently in endomyocardial biopsies from patients with dilated cardiomyopathy. Human erythroviruses cluster into three genotypes 1–3 which share a high degree of homology between major structural proteins and may cause indistinguishable infections clinically and serologically. In human cardiac tissue erythrovirus genotypes other than PVB19 have not yet been reported. Three hundred seventeen consecutive patients with symptomatic dilated cardiomyopathy (median left ventricular ejection fraction: 28.6%, range 5–45%) who underwent endomyocardial biopsy for the elucidation of the etiology, were analyzed using a new consensus PCR assay designed for the detection of the three erythrovirus genotype sequences. Endomyocardial biopsies of 151 (47.6%) patients were erythrovirus‐positive. Genotype 1 specific sequences were detected in 43/151 (28.5%) of positive biopsy samples, whereas genotype 2‐specific sequences so far considered rare in human disease and not yet been described in human heart tissue was identified in 108/151 (71.5%) of virus‐positive endomyocardial biopsies with a preference in patients above 50 years of age. In spite of younger age, systolic left ventricular dysfunction of genotype 1‐positive patients was significantly reduced as compared to genotype 2‐positive patients (24.4 ± 10.4% vs. 31.0 ± 9.5%, P = 0.0001) at the initial presentation. The data show that two genetically distinct erythrovirus variants with a different age distribution are detectable in endomyocardial biopsies of patients with dilated cardiomyopathy. The erythrovirus genotype 2, not described previously in human heart tissue, is highly prevalent in the heart but the less prevalent genotype 1 is associated with more severe disturbed cardiac function. J. Med. Virol. 80: 1243–1251, 2008. © 2008 Wiley‐Liss, Inc. Parvovirus B19 (PVB19) is a member of the human erythrovirus family detected frequently in endomyocardial biopsies from patients with dilated cardiomyopathy. Human erythroviruses cluster into three genotypes 1-3 which share a high degree of homology between major structural proteins and may cause indistinguishable infections clinically and serologically. In human cardiac tissue erythrovirus genotypes other than PVB19 have not yet been reported. Three hundred seventeen consecutive patients with symptomatic dilated cardiomyopathy (median left ventricular ejection fraction: 28.6%, range 5-45%) who underwent endomyocardial biopsy for the elucidation of the etiology, were analyzed using a new consensus PCR assay designed for the detection of the three erythrovirus genotype sequences. Endomyocardial biopsies of 151 (47.6%) patients were erythrovirus-positive. Genotype 1 specific sequences were detected in 43/151 (28.5%) of positive biopsy samples, whereas genotype 2-specific sequences so far considered rare in human disease and not yet been described in human heart tissue was identified in 108/151 (71.5%) of virus-positive endomyocardial biopsies with a preference in patients above 50 years of age. In spite of younger age, systolic left ventricular dysfunction of genotype 1-positive patients was significantly reduced as compared to genotype 2-positive patients (24.4+/-10.4% vs. 31.0+/-9.5%, P=0.0001) at the initial presentation. The data show that two genetically distinct erythrovirus variants with a different age distribution are detectable in endomyocardial biopsies of patients with dilated cardiomyopathy. The erythrovirus genotype 2, not described previously in human heart tissue, is highly prevalent in the heart but the less prevalent genotype 1 is associated with more severe disturbed cardiac function. |
| Author | Lassner, D Poller, W Schultheiss, H.-P Pauschinger, M Seeberg, B Noutsias, M Gross, U.M Kühl, U |
| Author_xml | – sequence: 1 fullname: Kühl, U – sequence: 2 fullname: Lassner, D – sequence: 3 fullname: Pauschinger, M – sequence: 4 fullname: Gross, U.M – sequence: 5 fullname: Seeberg, B – sequence: 6 fullname: Noutsias, M – sequence: 7 fullname: Poller, W – sequence: 8 fullname: Schultheiss, H.-P |
| BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=20366147$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/18461615$$D View this record in MEDLINE/PubMed |
| BookMark | eNqF0k9PFDEYBvDGYGRBD34BnYsmHAb6b9qZoyECKqJRwJtNt_uWLc5M17azON_eLrtgYqKc2nR-75O0z-ygrd73gNBzgvcJxvTgulvuU0Jq-QhNCG5E2WBJttAEEy5KIUi1jXZivMYY1w2lT9A2qbkg-XyCvn8OsNQt9AYKbwsIY5oHv3RhiMUV9D6NC4iF64s0h6IbvdFh5oZuZRc6OehTLG5cmhcz1-oEs-IW-Czz5_n4FD22uo3wbLPuooujt-eHJ-Xpp-N3h29OS8OllKWg1Ew5ZaKpdF2DNayuq7xYQ62oLLbALee0FqYyhBtTSyI5njKgDNiMTdkuer3OXQT_c4CYVOeigbbVPfghKtFQTJumehByKaqKC_YgpJjl5yWrxBcbOEw7mKlFcJ0Oo7p74wxebYCORrc26N64eO9yUK6Iy-z21s4EH2MA-ycKq1XPKvesbnvO9uAva1zKffg-Be3a_03cuBbGf0er9x8v7ybK9YSLCX7dT-jwQwnJZKW-nR0r2ZxdfvlwXqmj7F-uvdVe6auQ73jxlWLCVr-dqPPmN5Vm0d0 |
| CODEN | JMVIDB |
| CitedBy_id | crossref_primary_10_1111_eci_12223 crossref_primary_10_1002_jmv_21821 crossref_primary_10_1161_CIRCRESAHA_118_313578 crossref_primary_10_1161_CIRCULATIONAHA_124_070872 crossref_primary_10_4236_wjcd_2014_46042 crossref_primary_10_1007_s10528_019_09928_y crossref_primary_10_1016_j_tracli_2015_11_006 crossref_primary_10_3390_biomedicines9121898 crossref_primary_10_3390_ijms252010933 crossref_primary_10_1371_journal_pone_0176311 crossref_primary_10_1161_CIRCULATIONAHA_109_861534 crossref_primary_10_3390_v16010121 crossref_primary_10_1161_CIRCHEARTFAILURE_110_958249 crossref_primary_10_14218_JCTH_2017_00057 crossref_primary_10_1016_j_hlc_2012_07_013 crossref_primary_10_1093_molbev_msaa190 crossref_primary_10_5402_2013_898730 crossref_primary_10_1128_JCM_01672_08 crossref_primary_10_1038_s41598_020_78597_4 crossref_primary_10_1371_journal_pone_0113889 crossref_primary_10_1016_j_tracli_2009_09_001 crossref_primary_10_1002_ejhf_194 crossref_primary_10_1586_eri_11_135 crossref_primary_10_3390_v17030303 crossref_primary_10_3390_v11060566 crossref_primary_10_3390_jcm10225240 crossref_primary_10_1002_ejhf_665 crossref_primary_10_1136_bcr_2013_010410 crossref_primary_10_36233_0372_9311_2018_6_55_61 crossref_primary_10_1007_s00392_014_0709_z crossref_primary_10_1186_s12985_016_0611_6 crossref_primary_10_29328_journal_jccm_1001041 crossref_primary_10_1016_j_jcv_2008_09_007 crossref_primary_10_1002_jmv_21289 crossref_primary_10_3238_arztebl_2012_0361 crossref_primary_10_3892_mmr_2021_12399 crossref_primary_10_1007_s00059_009_3318_2 crossref_primary_10_1128_JCM_01201_09 crossref_primary_10_1002_smll_202303317 crossref_primary_10_1016_j_jcv_2010_09_010 crossref_primary_10_1007_s00431_009_1024_y crossref_primary_10_1016_S0140_6736_11_60648_X crossref_primary_10_1002_jmv_22187 crossref_primary_10_1016_j_healun_2010_03_003 crossref_primary_10_1016_j_cardfail_2009_12_016 crossref_primary_10_4103_ijmr_IJMR_1816_16 crossref_primary_10_1016_j_molimm_2011_04_013 crossref_primary_10_1007_s10741_017_9641_4 crossref_primary_10_1128_JVI_00684_10 crossref_primary_10_3390_jcm10091928 crossref_primary_10_1007_s00395_013_0372_y crossref_primary_10_1007_s00392_016_0986_9 crossref_primary_10_1016_j_virusres_2014_06_017 crossref_primary_10_1093_eurheartj_ehr165 crossref_primary_10_1128_JCM_00580_09 crossref_primary_10_1002_ehf2_12341 crossref_primary_10_4236_jasmi_2013_32012 |
| Cites_doi | 10.1128/JVI.76.4.2014-2018.2002 10.1002/jmv.2137 10.1161/01.CIR.0000072766.67150.51 10.1136/hrt.78.6.539 10.1161/CIRCULATIONAHA.105.548156 10.1161/01.CIR.0000155615.68924.B3 10.1006/viro.1995.1418 10.1128/jvi.61.8.2627-2630.1987 10.1128/jvi.58.3.921-936.1986 10.1016/j.jcv.2003.12.013 10.1007/s00430-003-0190-1 10.1161/01.CIR.0000160863.30496.9B 10.1161/01.CIR.0000085168.02782.2C 10.1016/S0046-8177(03)00235-1 10.1002/jmv.20251 10.1128/JVI.76.18.9124-9134.2002 10.1002/jmv.20049 10.1006/viro.2002.1673 10.1161/01.CIR.99.16.2124 10.1073/pnas.0402992101 10.1128/JCM.37.8.2483-2487.1999 10.1002/(SICI)1096-9071(199711)53:3<229::AID-JMV8>3.0.CO;2-A 10.1128/JVI.02713-06 10.1016/S1386-6532(03)00120-3 10.1128/CMR.15.3.485-505.2002 10.1016/S0735-1097(03)00648-X 10.1002/art.11038 10.1182/blood-2003-05-1522 10.1128/jvi.60.2.548-557.1986 10.1161/01.CIR.0000155616.07901.35 10.1053/hupa.2003.48 10.1073/pnas.0602259103 10.1002/jmv.1890390413 10.1016/j.virol.2003.09.011 10.1128/JVI.79.22.14197-14206.2005 10.1016/S1534-5807(01)00031-4 10.1161/01.CIR.99.10.1348 10.1161/01.CIR.0000048147.15962.31 |
| ContentType | Journal Article |
| Copyright | Copyright © 2008 Wiley‐Liss, Inc. 2008 INIST-CNRS |
| Copyright_xml | – notice: Copyright © 2008 Wiley‐Liss, Inc. – notice: 2008 INIST-CNRS |
| DBID | FBQ BSCLL AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7U9 H94 7S9 L.6 7X8 |
| DOI | 10.1002/jmv.21187 |
| DatabaseName | AGRIS Istex CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Virology and AIDS Abstracts AIDS and Cancer Research Abstracts AGRICOLA AGRICOLA - Academic MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) AIDS and Cancer Research Abstracts Virology and AIDS Abstracts AGRICOLA AGRICOLA - Academic MEDLINE - Academic |
| DatabaseTitleList | AIDS and Cancer Research Abstracts CrossRef MEDLINE - Academic AGRICOLA MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: FBQ name: AGRIS url: http://www.fao.org/agris/Centre.asp?Menu_1ID=DB&Menu_2ID=DB1&Language=EN&Content=http://www.fao.org/agris/search?Language=EN sourceTypes: Publisher |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Medicine |
| EISSN | 1096-9071 |
| EndPage | 1251 |
| ExternalDocumentID | 18461615 20366147 10_1002_jmv_21187 JMV21187 ark_67375_WNG_79NVRKT5_F US201300896801 |
| Genre | article Research Support, Non-U.S. Gov't Journal Article |
| GrantInformation_xml | – fundername: Transregional Collaborative Research Centre “Inflammatory Cardiomyopathy—Molecular Pathogenesis and Therapy” funderid: SFB TR 19 – fundername: German Research Foundation (DFG) |
| GroupedDBID | --- .3N .55 .GA .GJ .Y3 05W 0R~ 10A 1L6 1OB 1OC 1ZS 31~ 33P 3O- 3SF 3WU 4.4 50Y 50Z 51W 51X 52M 52N 52O 52P 52R 52S 52T 52U 52V 52W 52X 53G 5GY 5RE 5VS 66C 702 7PT 8-0 8-1 8-3 8-4 8-5 8UM 930 A01 A03 AAESR AAEVG AAHHS AANLZ AAONW AASGY AAVGM AAXRX AAZKR ABCQN ABCUV ABEML ABHUG ABIJN ABJNI ABOCM ABPVW ABQWH ABXGK ACAHQ ACBWZ ACCFJ ACCZN ACGFS ACGOF ACMXC ACPOU ACPRK ACSCC ACXBN ACXME ACXQS ADAWD ADBBV ADBTR ADDAD ADEOM ADIZJ ADKYN ADMGS ADOZA ADXAS ADZMN AEEZP AEIGN AEIMD AENEX AEQDE AEQTP AEUQT AEUYR AFBPY AFFNX AFFPM AFGKR AFPWT AFRAH AFVGU AFZJQ AGJLS AHMBA AI. AIACR AIURR AIWBW AJBDE ALAGY ALMA_UNASSIGNED_HOLDINGS ALUQN AMBMR AMYDB ASPBG ATUGU AVWKF AZBYB AZFZN AZVAB BAFTC BDRZF BFHJK BHBCM BMXJE BROTX BRXPI BY8 C45 CS3 D-6 D-7 D-E D-F DCZOG DPXWK DR2 DRFUL DRMAN DRSTM DU5 EBD EBS ECGQY EJD ELTNK EMOBN F00 F01 F04 F5P FBQ FEDTE FUBAC G-S G.N GNP GODZA H.X HBH HF~ HHY HHZ HVGLF HZ~ IX1 J0M JPC KBYEO KQQ L7B LATKE LAW LC2 LC3 LEEKS LH4 LITHE LOXES LP6 LP7 LUTES LW6 LYRES M65 MEWTI MK4 MRFUL MRMAN MRSTM MSFUL MSMAN MSSTM MXFUL MXMAN MXSTM N04 N05 N9A NF~ NNB O66 O9- OVD P2P P2W P2X P2Z P4B P4D PALCI PQQKQ Q.N Q11 QB0 QRW R.K RGB RIWAO RJQFR ROL RWI RX1 RYL SAMSI SUPJJ SV3 TEORI TUS UB1 V2E VH1 W8V W99 WBKPD WHG WIB WIH WIJ WIK WJL WNSPC WOHZO WQJ WRC WUP WXI WXSBR WYISQ X7M XG1 XPP XV2 ZGI ZXP ZZTAW ~IA ~KM ~WT AAHQN AAIPD AAMMB AAMNL AANHP AAYCA ACRPL ACYXJ ADNMO AEFGJ AEYWJ AFWVQ AGHNM AGQPQ AGXDD AGYGG AHBTC AIDQK AIDYY AITYG ALVPJ BSCLL HGLYW OIG AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7U9 H94 7S9 L.6 7X8 |
| ID | FETCH-LOGICAL-c4777-622cb423695a88efc3885efcfc2f65f0fe4f44286c5c14cc871740b3e23e3d3b3 |
| IEDL.DBID | DR2 |
| ISSN | 0146-6615 |
| IngestDate | Fri Sep 05 02:54:26 EDT 2025 Thu Sep 04 15:52:33 EDT 2025 Thu Sep 04 23:36:24 EDT 2025 Thu Apr 03 07:06:27 EDT 2025 Mon Jul 21 09:15:41 EDT 2025 Tue Jul 01 02:24:20 EDT 2025 Thu Apr 24 23:10:56 EDT 2025 Wed Jan 22 16:24:44 EST 2025 Tue Sep 09 05:32:26 EDT 2025 Wed Dec 27 19:19:43 EST 2023 |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 7 |
| Keywords | Human Heart failure Prevalence genotypes Cardiovascular disease Genotype Erythrovirus Myocardial disease Virus Dilated cardiomyopathy Parvoviridae Heart disease Molecular epidemiology Myocardium Parvovirinae |
| Language | English |
| License | http://onlinelibrary.wiley.com/termsAndConditions#vor CC BY 4.0 |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c4777-622cb423695a88efc3885efcfc2f65f0fe4f44286c5c14cc871740b3e23e3d3b3 |
| Notes | http://dx.doi.org/10.1002/jmv.21187 German Research Foundation (DFG) Transregional Collaborative Research Centre "Inflammatory Cardiomyopathy-Molecular Pathogenesis and Therapy" - No. SFB TR 19 ark:/67375/WNG-79NVRKT5-F U. Kühl and D. Lassner contributed equally to this study. ArticleID:JMV21187 istex:38B9EF2A0922B4C4D9131DEC2C6E01BD74E0359C ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| PMID | 18461615 |
| PQID | 20301415 |
| PQPubID | 23462 |
| PageCount | 9 |
| ParticipantIDs | proquest_miscellaneous_69202995 proquest_miscellaneous_47655463 proquest_miscellaneous_20301415 pubmed_primary_18461615 pascalfrancis_primary_20366147 crossref_primary_10_1002_jmv_21187 crossref_citationtrail_10_1002_jmv_21187 wiley_primary_10_1002_jmv_21187_JMV21187 istex_primary_ark_67375_WNG_79NVRKT5_F fao_agris_US201300896801 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | July 2008 |
| PublicationDateYYYYMMDD | 2008-07-01 |
| PublicationDate_xml | – month: 07 year: 2008 text: July 2008 |
| PublicationDecade | 2000 |
| PublicationPlace | Hoboken |
| PublicationPlace_xml | – name: Hoboken – name: New York, NY – name: United States |
| PublicationTitle | Journal of medical virology |
| PublicationTitleAlternate | J. Med. Virol |
| PublicationYear | 2008 |
| Publisher | Wiley Subscription Services, Inc., A Wiley Company Wiley-Liss |
| Publisher_xml | – name: Wiley Subscription Services, Inc., A Wiley Company – name: Wiley-Liss |
| References | Blumel J, Eis-Hubinger AM, Stuhler A, Bonsch C, Gessner M, Lower J. 2005. Characterization of parvovirus B19 genotype 2 in KU812Ep6 cells. J Virol 79: 14197-14206. Zhi N, Zadori Z, Brown KE, Tijssen P. 2004. Construction and sequencing of an infectious clone of the human parvovirus B19. Virology 318: 142-152. Bowles NE, Ni J, Kearney DL, Pauschinger M, Schultheiss HP, McCarthy R, Hare J, Bricker JT, Bowles KR, Towbin JA. 2003. Detection of viruses in myocardial tissues by polymerase chain reaction evidence of adenovirus as a common cause of myocarditis in children and adults. J Am Coll Cardiol 42: 466-472. Ozawa K, Young NS. 1987. Characterization of capsid and noncapsid proteins of B19 parvovirus propagated in human erythroid bone marrow cell cultures. J Virol 61: 2627-2630. Frustaci A, Chimenti C, Calabrese F, Pieroni M, Thiene G, Maseri A. 2003. Immunosuppressive therapy for active lymphocytic myocarditis: Virological and immunologic profile of responders versus nonresponders. Circulation 107: 857-863. Liefeldt L, Plentz A, Klempa B, Kershaw O, Endres AS, Raab U, Neumayer HH, Meisel H, Modrow S. 2005. Recurrent high level parvovirus B19/genotype 2 viremia in a renal transplant recipient analyzed by real-time PCR for simultaneous detection of genotypes 1 to 3. J Med Virol 75: 161-169. von Landenberg P, Lehmann HW, Knoll A, Dorsch S, Modrow S. 2003. Antiphospholipid antibodies in pediatric and adult patients with rheumatic disease are associated with parvovirus B19 infection. Arthritis Rheum 48: 1939-1947. Gallinella G, Venturoli S, Manaresi E, Musiani M, Zerbini M. 2003. B19 virus genome diversity: Epidemiological and clinical correlations. J Clin Virol 28: 1-13. Kawase M, Momoeda M, Young NS, Kajigaya S. 1995. Most of the VP1 unique region of B19 parvovirus is on the capsid surface. Virology 211: 359-366. Hokynar K, Soderlund-Venermo M, Pesonen M, Ranki A, Kiviluoto O, Partio EK, Hedman K. 2002. A new parvovirus genotype persistent in human skin. Virology 302: 224-228. Servant A, Laperche S, Lallemand F, Marinho V, De Saint Maur G, Meritet JF, Garbarg-Chenon A. 2002. Genetic diversity within human erythroviruses: Identification of three genotypes. J Virol 76: 9124-9134. Tschope C, Bock CT, Kasner M, Noutsias M, Westermann D, Schwimmbeck PL, Pauschinger M, Poller WC, Kuhl U, Kandolf R, Schultheiss HP. 2005. High prevalence of cardiac parvovirus B19 infection in patients with isolated left ventricular diastolic dysfunction. Circulation 111: 879-886. Cotmore SF, McKie VC, Anderson LJ, Astell CR, Tattersall P. 1986. Identification of the major structural and nonstructural proteins encoded by human parvovirus B19 and mapping of their genes by procaryotic expression of isolated genomic fragments. J Virol 60: 548-557. Heegaard ED, Brown KE. 2002. Human parvovirus B19. Clin Microbiol Rev 15: 485-505. Schalasta G, Schmid M, Lachmund T, Enders G. 2004. LightCycler consensus PCR for rapid and differential detection of human erythrovirus B19 and V9 isolates. J Med Virol 73: 54-59. Kühl U, Pauschinger M, Noutsias M, Seeberg B, Bock T, Lassner D, Poller W, Kandolf R, Schultheiss HP. 2005a. High prevalence of viral genomes and multiple viral infections in the myocardium of adults with "idiopathic" left ventricular dysfunction. Circulation 111: 887-893. Umene K, Nunoue T. 1993. Partial nucleotide sequencing and characterization of human parvovirus B19 genome DNAs from damaged human fetuses and from patients with leukemia. J Med Virol 39: 333-339. Heegaard ED, Qvortrup K, Christensen J. 2002. Baculovirus expression of erythrovirus V9 capsids and screening by ELISA: Serologic cross-reactivity with erythrovirus B19. J Med Virol 66: 246-252. Vallbracht KB, Schwimmbeck PL, Kuhl U, Rauch U, Seeberg B, Schultheiss HP. 2005. Differential aspects of endothelial function of the coronary microcirculation considering myocardial virus persistence, endothelial activation, and myocardial leukocyte infiltrates. Circulation 111: 1784-1791. Zadori Z, Szelei J, Lacoste MC. 2001. A viral phospholipase A2 is required for parvovirus infectivity. Dev Cell 1: 291-302. Ekman A, Hokynar K, Kakkola L, Kantola K, Hedman L, Bondén H, Gessner M, Aberham C, Norja P, Miettinen S, Hedman K, Söderlund-Venermo M. 2007. Biological and immunological relations among human parvovirus B19 genotypes 1 to 3. J Virol 81: 6927-6935. Baboonian C, Treasure T. 1997. Meta-analysis of the association of enteroviruses with human heart disease. Heart 78: 539-543. Dorsch S, Liebsch G, Kaufmann B, von Landenberg P, Hoffmann JH, Drobnik W, Modrow S. 2002. The VP1 unique region of parvovirus B19 and its constituent phospholipase A2-like activity. J Virol 76: 2014-2018. Lamparter S, Schoppet M, Pankuweit S, Maisch B. 2003. Acute parvovirus B19 infection associated with myocarditis in an immunocompetent adult. Hum Pathol 34: 725-728. Kühl U, Pauschinger M, Schwimmbeck PL, Seeberg B, Lober C, Noutsias M, Poller W, Schultheiss HP. 2003b. Interferon-beta treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction. Circulation 107: 2793-2798. Bueltmann BD, Klingel K, Soltar K, Bock CT, Baba HA, Sauter M, Kandolf R. 2002. Fatal Parvovirus B19-associated myocarditis clinically mimicking ischemic heart disease: An endothelial cell-mediated disease. Hum Pathol 34: 92-95. Kühl U, Pauschinger M, Bock T, Klingel K, Schwimmbeck CP, Seeberg B, Krautwurm L, Poller W, Schultheiss HP, Kandolf R. 2003a. Parvovirus B19 infection mimicking acute myocardial infarction. Circulation 108: 945-950. Noutsias M, Seeberg B, Schultheiss HP, Kuhl U. 1999. Expression of cell adhesion molecules in dilated cardiomyopathy: Evidence for endothelial activation in inflammatory cardiomyopathy. Circulation 99: 2124-2131. Weigel-Kelley KA, Yoder MC, Srivastava A. 2003. Alpha5beta1 integrin as a cellular coreceptor for human parvovirus B19: Requirement of functional activation of beta1 integrin for viral entry. Blood 102: 3927-3933. Nguyen QT, Sifer C, Schneider V, Allaume X, Servant A, Bernaudin F, Auguste V, Garbarg-Chenon A. 1999. Novel human erythrovirus associated with transient aplastic anemia. J Clin Microbiol 37: 2483-2487. Norja P, Hokynar K, Aaltonen LM, Chen R, Ranki A, Partio EK, Kiviluoto O, Davidkin I, Leivo T, Eis-Hubinger AM, Schneider B, Fischer HP, Tolba R, Vapalahti O, Vaheri A, Soderlund-Venermo M, Hedman K. 2006. Bioportfolio: Lifelong persistence of variant and prototypic erythrovirus DNA genomes in human tissue. Proc Natl Acad Sci USA 103: 7450-7453. Donoso Mantke O, Nitsche A, Meyer R, Klingel K, Niedrig M, 2004. Analysing myocardial tissue from explanted hearts of heart transplant recipients and multi-organ donors for the presence of parvovirus B19 DNA. J Clin Virol 31: 32-39. Kaufmann B, Simpson AA, Rossmann MG. 2004. The structure of human parvovirus B19. Proc Natl Acad Sci 101: 11628-11633. Pauschinger M, Bowles NE, Fuentes-Garcia FJ, Pham V, Kuhl U, Schwimmbeck PL, Schultheiss HP, Towbin JA. 1999. Detection of adenoviral genome in the myocardium of adult patients with idiopathic left ventricular dysfunction. Circulation 99: 1348-1354. Klingel K, Sauter M, Bock CT, Szalay G, Schnorr JJ, Kandolf R. 2004. Molecular pathology of inflammatory cardiomyopathy. Med Microbiol Immunol (Berl) 193: 101-107. Kühl U, Pauschinger M, Seeberg B, Lassner D, Noutsias M, Poller W, Schultheiss HP. 2005b. Viral persistence in the myocardium is associated with progressive cardiac dysfunction. Circulation 112: 1965-1970. Shade RO, Blundell MC, Cotmore SF, Tattersall PC, Astell CR. 1986. Nucleotide sequence and genome organization of human parvovirus B19 isolated from the serum of a child during aplastic crisis. J Virol 58: 921-936. Cassinotti P, Burtonboy G, Fopp M, Siegl G. 1997. Evidence for persistence of human parvovirus B19 DNA in bone marrow. J Med Virol 53: 229-232. 2004; 101 2002; 15 2003a; 108 2005; 111 2005a; 111 2002; 34 2002; 76 1986; 58 1995; 211 2005b; 112 2003; 34 2004; 31 1986; 60 2003; 107 2004; 73 1993; 39 1987; 61 1997; 53 1999; 37 1997; 78 2002; 66 2004; 193 2002; 302 2005; 75 1999; 99 2003; 48 2007; 81 2003; 28 2001; 1 2004; 318 2003; 102 2003; 42 2005; 79 2003b; 107 2006; 103 e_1_2_1_20_1 e_1_2_1_23_1 e_1_2_1_24_1 e_1_2_1_21_1 e_1_2_1_22_1 e_1_2_1_27_1 e_1_2_1_28_1 e_1_2_1_25_1 e_1_2_1_26_1 e_1_2_1_29_1 e_1_2_1_7_1 e_1_2_1_31_1 e_1_2_1_8_1 e_1_2_1_30_1 e_1_2_1_5_1 e_1_2_1_6_1 e_1_2_1_3_1 e_1_2_1_12_1 e_1_2_1_35_1 e_1_2_1_4_1 e_1_2_1_13_1 e_1_2_1_34_1 e_1_2_1_10_1 e_1_2_1_33_1 e_1_2_1_2_1 e_1_2_1_11_1 e_1_2_1_32_1 e_1_2_1_16_1 e_1_2_1_39_1 e_1_2_1_17_1 e_1_2_1_38_1 e_1_2_1_14_1 e_1_2_1_37_1 e_1_2_1_15_1 e_1_2_1_36_1 e_1_2_1_9_1 e_1_2_1_18_1 e_1_2_1_19_1 |
| References_xml | – reference: Bowles NE, Ni J, Kearney DL, Pauschinger M, Schultheiss HP, McCarthy R, Hare J, Bricker JT, Bowles KR, Towbin JA. 2003. Detection of viruses in myocardial tissues by polymerase chain reaction evidence of adenovirus as a common cause of myocarditis in children and adults. J Am Coll Cardiol 42: 466-472. – reference: Blumel J, Eis-Hubinger AM, Stuhler A, Bonsch C, Gessner M, Lower J. 2005. Characterization of parvovirus B19 genotype 2 in KU812Ep6 cells. J Virol 79: 14197-14206. – reference: Kawase M, Momoeda M, Young NS, Kajigaya S. 1995. Most of the VP1 unique region of B19 parvovirus is on the capsid surface. Virology 211: 359-366. – reference: Weigel-Kelley KA, Yoder MC, Srivastava A. 2003. Alpha5beta1 integrin as a cellular coreceptor for human parvovirus B19: Requirement of functional activation of beta1 integrin for viral entry. Blood 102: 3927-3933. – reference: Cassinotti P, Burtonboy G, Fopp M, Siegl G. 1997. Evidence for persistence of human parvovirus B19 DNA in bone marrow. J Med Virol 53: 229-232. – reference: Lamparter S, Schoppet M, Pankuweit S, Maisch B. 2003. Acute parvovirus B19 infection associated with myocarditis in an immunocompetent adult. Hum Pathol 34: 725-728. – reference: Zhi N, Zadori Z, Brown KE, Tijssen P. 2004. Construction and sequencing of an infectious clone of the human parvovirus B19. Virology 318: 142-152. – reference: Noutsias M, Seeberg B, Schultheiss HP, Kuhl U. 1999. Expression of cell adhesion molecules in dilated cardiomyopathy: Evidence for endothelial activation in inflammatory cardiomyopathy. Circulation 99: 2124-2131. – reference: Tschope C, Bock CT, Kasner M, Noutsias M, Westermann D, Schwimmbeck PL, Pauschinger M, Poller WC, Kuhl U, Kandolf R, Schultheiss HP. 2005. High prevalence of cardiac parvovirus B19 infection in patients with isolated left ventricular diastolic dysfunction. Circulation 111: 879-886. – reference: Klingel K, Sauter M, Bock CT, Szalay G, Schnorr JJ, Kandolf R. 2004. Molecular pathology of inflammatory cardiomyopathy. Med Microbiol Immunol (Berl) 193: 101-107. – reference: Hokynar K, Soderlund-Venermo M, Pesonen M, Ranki A, Kiviluoto O, Partio EK, Hedman K. 2002. A new parvovirus genotype persistent in human skin. Virology 302: 224-228. – reference: Kaufmann B, Simpson AA, Rossmann MG. 2004. The structure of human parvovirus B19. Proc Natl Acad Sci 101: 11628-11633. – reference: Dorsch S, Liebsch G, Kaufmann B, von Landenberg P, Hoffmann JH, Drobnik W, Modrow S. 2002. The VP1 unique region of parvovirus B19 and its constituent phospholipase A2-like activity. J Virol 76: 2014-2018. – reference: Donoso Mantke O, Nitsche A, Meyer R, Klingel K, Niedrig M, 2004. Analysing myocardial tissue from explanted hearts of heart transplant recipients and multi-organ donors for the presence of parvovirus B19 DNA. J Clin Virol 31: 32-39. – reference: Bueltmann BD, Klingel K, Soltar K, Bock CT, Baba HA, Sauter M, Kandolf R. 2002. Fatal Parvovirus B19-associated myocarditis clinically mimicking ischemic heart disease: An endothelial cell-mediated disease. Hum Pathol 34: 92-95. – reference: Ozawa K, Young NS. 1987. Characterization of capsid and noncapsid proteins of B19 parvovirus propagated in human erythroid bone marrow cell cultures. J Virol 61: 2627-2630. – reference: Baboonian C, Treasure T. 1997. Meta-analysis of the association of enteroviruses with human heart disease. Heart 78: 539-543. – reference: Kühl U, Pauschinger M, Schwimmbeck PL, Seeberg B, Lober C, Noutsias M, Poller W, Schultheiss HP. 2003b. Interferon-beta treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction. Circulation 107: 2793-2798. – reference: Kühl U, Pauschinger M, Seeberg B, Lassner D, Noutsias M, Poller W, Schultheiss HP. 2005b. Viral persistence in the myocardium is associated with progressive cardiac dysfunction. Circulation 112: 1965-1970. – reference: Heegaard ED, Brown KE. 2002. Human parvovirus B19. Clin Microbiol Rev 15: 485-505. – reference: Schalasta G, Schmid M, Lachmund T, Enders G. 2004. LightCycler consensus PCR for rapid and differential detection of human erythrovirus B19 and V9 isolates. J Med Virol 73: 54-59. – reference: Shade RO, Blundell MC, Cotmore SF, Tattersall PC, Astell CR. 1986. Nucleotide sequence and genome organization of human parvovirus B19 isolated from the serum of a child during aplastic crisis. J Virol 58: 921-936. – reference: von Landenberg P, Lehmann HW, Knoll A, Dorsch S, Modrow S. 2003. Antiphospholipid antibodies in pediatric and adult patients with rheumatic disease are associated with parvovirus B19 infection. Arthritis Rheum 48: 1939-1947. – reference: Gallinella G, Venturoli S, Manaresi E, Musiani M, Zerbini M. 2003. B19 virus genome diversity: Epidemiological and clinical correlations. J Clin Virol 28: 1-13. – reference: Pauschinger M, Bowles NE, Fuentes-Garcia FJ, Pham V, Kuhl U, Schwimmbeck PL, Schultheiss HP, Towbin JA. 1999. Detection of adenoviral genome in the myocardium of adult patients with idiopathic left ventricular dysfunction. Circulation 99: 1348-1354. – reference: Kühl U, Pauschinger M, Noutsias M, Seeberg B, Bock T, Lassner D, Poller W, Kandolf R, Schultheiss HP. 2005a. High prevalence of viral genomes and multiple viral infections in the myocardium of adults with "idiopathic" left ventricular dysfunction. Circulation 111: 887-893. – reference: Kühl U, Pauschinger M, Bock T, Klingel K, Schwimmbeck CP, Seeberg B, Krautwurm L, Poller W, Schultheiss HP, Kandolf R. 2003a. Parvovirus B19 infection mimicking acute myocardial infarction. Circulation 108: 945-950. – reference: Zadori Z, Szelei J, Lacoste MC. 2001. A viral phospholipase A2 is required for parvovirus infectivity. Dev Cell 1: 291-302. – reference: Servant A, Laperche S, Lallemand F, Marinho V, De Saint Maur G, Meritet JF, Garbarg-Chenon A. 2002. Genetic diversity within human erythroviruses: Identification of three genotypes. J Virol 76: 9124-9134. – reference: Ekman A, Hokynar K, Kakkola L, Kantola K, Hedman L, Bondén H, Gessner M, Aberham C, Norja P, Miettinen S, Hedman K, Söderlund-Venermo M. 2007. Biological and immunological relations among human parvovirus B19 genotypes 1 to 3. J Virol 81: 6927-6935. – reference: Heegaard ED, Qvortrup K, Christensen J. 2002. Baculovirus expression of erythrovirus V9 capsids and screening by ELISA: Serologic cross-reactivity with erythrovirus B19. J Med Virol 66: 246-252. – reference: Umene K, Nunoue T. 1993. Partial nucleotide sequencing and characterization of human parvovirus B19 genome DNAs from damaged human fetuses and from patients with leukemia. J Med Virol 39: 333-339. – reference: Norja P, Hokynar K, Aaltonen LM, Chen R, Ranki A, Partio EK, Kiviluoto O, Davidkin I, Leivo T, Eis-Hubinger AM, Schneider B, Fischer HP, Tolba R, Vapalahti O, Vaheri A, Soderlund-Venermo M, Hedman K. 2006. Bioportfolio: Lifelong persistence of variant and prototypic erythrovirus DNA genomes in human tissue. Proc Natl Acad Sci USA 103: 7450-7453. – reference: Liefeldt L, Plentz A, Klempa B, Kershaw O, Endres AS, Raab U, Neumayer HH, Meisel H, Modrow S. 2005. Recurrent high level parvovirus B19/genotype 2 viremia in a renal transplant recipient analyzed by real-time PCR for simultaneous detection of genotypes 1 to 3. J Med Virol 75: 161-169. – reference: Nguyen QT, Sifer C, Schneider V, Allaume X, Servant A, Bernaudin F, Auguste V, Garbarg-Chenon A. 1999. Novel human erythrovirus associated with transient aplastic anemia. J Clin Microbiol 37: 2483-2487. – reference: Cotmore SF, McKie VC, Anderson LJ, Astell CR, Tattersall P. 1986. Identification of the major structural and nonstructural proteins encoded by human parvovirus B19 and mapping of their genes by procaryotic expression of isolated genomic fragments. J Virol 60: 548-557. – reference: Vallbracht KB, Schwimmbeck PL, Kuhl U, Rauch U, Seeberg B, Schultheiss HP. 2005. Differential aspects of endothelial function of the coronary microcirculation considering myocardial virus persistence, endothelial activation, and myocardial leukocyte infiltrates. Circulation 111: 1784-1791. – reference: Frustaci A, Chimenti C, Calabrese F, Pieroni M, Thiene G, Maseri A. 2003. Immunosuppressive therapy for active lymphocytic myocarditis: Virological and immunologic profile of responders versus nonresponders. Circulation 107: 857-863. – volume: 39 start-page: 333 year: 1993 end-page: 339 article-title: Partial nucleotide sequencing and characterization of human parvovirus B19 genome DNAs from damaged human fetuses and from patients with leukemia publication-title: J Med Virol – volume: 111 start-page: 1784 year: 2005 end-page: 1791 article-title: Differential aspects of endothelial function of the coronary microcirculation considering myocardial virus persistence, endothelial activation, and myocardial leukocyte infiltrates publication-title: Circulation – volume: 66 start-page: 246 year: 2002 end-page: 252 article-title: Baculovirus expression of erythrovirus V9 capsids and screening by ELISA: Serologic cross‐reactivity with erythrovirus B19 publication-title: J Med Virol – volume: 318 start-page: 142 year: 2004 end-page: 152 article-title: Construction and sequencing of an infectious clone of the human parvovirus B19 publication-title: Virology – volume: 108 start-page: 945 year: 2003a end-page: 950 article-title: Parvovirus B19 infection mimicking acute myocardial infarction publication-title: Circulation – volume: 73 start-page: 54 year: 2004 end-page: 59 article-title: LightCycler consensus PCR for rapid and differential detection of human erythrovirus B19 and V9 isolates publication-title: J Med Virol – volume: 60 start-page: 548 year: 1986 end-page: 557 article-title: Identification of the major structural and nonstructural proteins encoded by human parvovirus B19 and mapping of their genes by procaryotic expression of isolated genomic fragments publication-title: J Virol – volume: 211 start-page: 359 year: 1995 end-page: 366 article-title: Most of the VP1 unique region of B19 parvovirus is on the capsid surface publication-title: Virology – volume: 99 start-page: 2124 year: 1999 end-page: 2131 article-title: Expression of cell adhesion molecules in dilated cardiomyopathy: Evidence for endothelial activation in inflammatory cardiomyopathy publication-title: Circulation – volume: 15 start-page: 485 year: 2002 end-page: 505 article-title: Human parvovirus B19 publication-title: Clin Microbiol Rev – volume: 102 start-page: 3927 year: 2003 end-page: 3933 article-title: Alpha5beta1 integrin as a cellular coreceptor for human parvovirus B19: Requirement of functional activation of beta1 integrin for viral entry publication-title: Blood – volume: 101 start-page: 11628 year: 2004 end-page: 11633 article-title: The structure of human parvovirus B19 publication-title: Proc Natl Acad Sci – volume: 1 start-page: 291 year: 2001 end-page: 302 article-title: A viral phospholipase A2 is required for parvovirus infectivity publication-title: Dev Cell – volume: 103 start-page: 7450 year: 2006 end-page: 7453 article-title: Bioportfolio: Lifelong persistence of variant and prototypic erythrovirus DNA genomes in human tissue publication-title: Proc Natl Acad Sci USA – volume: 193 start-page: 101 year: 2004 end-page: 107 article-title: Molecular pathology of inflammatory cardiomyopathy publication-title: Med Microbiol Immunol (Berl) – volume: 48 start-page: 1939 year: 2003 end-page: 1947 article-title: Antiphospholipid antibodies in pediatric and adult patients with rheumatic disease are associated with parvovirus B19 infection publication-title: Arthritis Rheum – volume: 99 start-page: 1348 year: 1999 end-page: 1354 article-title: Detection of adenoviral genome in the myocardium of adult patients with idiopathic left ventricular dysfunction publication-title: Circulation – volume: 53 start-page: 229 year: 1997 end-page: 232 article-title: Evidence for persistence of human parvovirus B19 DNA in bone marrow publication-title: J Med Virol – volume: 31 start-page: 32 year: 2004 end-page: 39 article-title: Analysing myocardial tissue from explanted hearts of heart transplant recipients and multi‐organ donors for the presence of parvovirus B19 DNA publication-title: J Clin Virol – volume: 112 start-page: 1965 year: 2005b end-page: 1970 article-title: Viral persistence in the myocardium is associated with progressive cardiac dysfunction publication-title: Circulation – volume: 111 start-page: 887 year: 2005a end-page: 893 article-title: High prevalence of viral genomes and multiple viral infections in the myocardium of adults with “idiopathic” left ventricular dysfunction publication-title: Circulation – volume: 302 start-page: 224 year: 2002 end-page: 228 article-title: A new parvovirus genotype persistent in human skin publication-title: Virology – volume: 76 start-page: 2014 year: 2002 end-page: 2018 article-title: The VP1 unique region of parvovirus B19 and its constituent phospholipase A2‐like activity publication-title: J Virol – volume: 37 start-page: 2483 year: 1999 end-page: 2487 article-title: Novel human erythrovirus associated with transient aplastic anemia publication-title: J Clin Microbiol – volume: 42 start-page: 466 year: 2003 end-page: 472 article-title: Detection of viruses in myocardial tissues by polymerase chain reaction evidence of adenovirus as a common cause of myocarditis in children and adults publication-title: J Am Coll Cardiol – volume: 34 start-page: 92 year: 2002 end-page: 95 article-title: Fatal Parvovirus B19‐associated myocarditis clinically mimicking ischemic heart disease: An endothelial cell‐mediated disease publication-title: Hum Pathol – volume: 107 start-page: 857 year: 2003 end-page: 863 article-title: Immunosuppressive therapy for active lymphocytic myocarditis: Virological and immunologic profile of responders versus nonresponders publication-title: Circulation – volume: 28 start-page: 1 year: 2003 end-page: 13 article-title: B19 virus genome diversity: Epidemiological and clinical correlations publication-title: J Clin Virol – volume: 61 start-page: 2627 year: 1987 end-page: 2630 article-title: Characterization of capsid and noncapsid proteins of B19 parvovirus propagated in human erythroid bone marrow cell cultures publication-title: J Virol – volume: 75 start-page: 161 year: 2005 end-page: 169 article-title: Recurrent high level parvovirus B19/genotype 2 viremia in a renal transplant recipient analyzed by real‐time PCR for simultaneous detection of genotypes 1 to 3 publication-title: J Med Virol – volume: 78 start-page: 539 year: 1997 end-page: 543 article-title: Meta‐analysis of the association of enteroviruses with human heart disease publication-title: Heart – volume: 81 start-page: 6927 year: 2007 end-page: 6935 article-title: Biological and immunological relations among human parvovirus B19 genotypes 1 to 3 publication-title: J Virol – volume: 76 start-page: 9124 year: 2002 end-page: 9134 article-title: Genetic diversity within human erythroviruses: Identification of three genotypes publication-title: J Virol – volume: 58 start-page: 921 year: 1986 end-page: 936 article-title: Nucleotide sequence and genome organization of human parvovirus B19 isolated from the serum of a child during aplastic crisis publication-title: J Virol – volume: 34 start-page: 725 year: 2003 end-page: 728 article-title: Acute parvovirus B19 infection associated with myocarditis in an immunocompetent adult publication-title: Hum Pathol – volume: 111 start-page: 879 year: 2005 end-page: 886 article-title: High prevalence of cardiac parvovirus B19 infection in patients with isolated left ventricular diastolic dysfunction publication-title: Circulation – volume: 107 start-page: 2793 year: 2003b end-page: 2798 article-title: Interferon‐beta treatment eliminates cardiotropic viruses and improves left ventricular function in patients with myocardial persistence of viral genomes and left ventricular dysfunction publication-title: Circulation – volume: 79 start-page: 14197 year: 2005 end-page: 14206 article-title: Characterization of parvovirus B19 genotype 2 in KU812Ep6 cells publication-title: J Virol – ident: e_1_2_1_9_1 doi: 10.1128/JVI.76.4.2014-2018.2002 – ident: e_1_2_1_14_1 doi: 10.1002/jmv.2137 – ident: e_1_2_1_20_1 doi: 10.1161/01.CIR.0000072766.67150.51 – ident: e_1_2_1_2_1 doi: 10.1136/hrt.78.6.539 – ident: e_1_2_1_22_1 doi: 10.1161/CIRCULATIONAHA.105.548156 – ident: e_1_2_1_33_1 doi: 10.1161/01.CIR.0000155615.68924.B3 – ident: e_1_2_1_17_1 doi: 10.1006/viro.1995.1418 – ident: e_1_2_1_28_1 doi: 10.1128/jvi.61.8.2627-2630.1987 – ident: e_1_2_1_32_1 doi: 10.1128/jvi.58.3.921-936.1986 – ident: e_1_2_1_8_1 doi: 10.1016/j.jcv.2003.12.013 – ident: e_1_2_1_18_1 doi: 10.1007/s00430-003-0190-1 – ident: e_1_2_1_35_1 doi: 10.1161/01.CIR.0000160863.30496.9B – ident: e_1_2_1_19_1 doi: 10.1161/01.CIR.0000085168.02782.2C – ident: e_1_2_1_23_1 doi: 10.1016/S0046-8177(03)00235-1 – ident: e_1_2_1_24_1 doi: 10.1002/jmv.20251 – ident: e_1_2_1_31_1 doi: 10.1128/JVI.76.18.9124-9134.2002 – ident: e_1_2_1_30_1 doi: 10.1002/jmv.20049 – ident: e_1_2_1_15_1 doi: 10.1006/viro.2002.1673 – ident: e_1_2_1_27_1 doi: 10.1161/01.CIR.99.16.2124 – ident: e_1_2_1_16_1 doi: 10.1073/pnas.0402992101 – ident: e_1_2_1_25_1 doi: 10.1128/JCM.37.8.2483-2487.1999 – ident: e_1_2_1_6_1 doi: 10.1002/(SICI)1096-9071(199711)53:3<229::AID-JMV8>3.0.CO;2-A – ident: e_1_2_1_10_1 doi: 10.1128/JVI.02713-06 – ident: e_1_2_1_12_1 doi: 10.1016/S1386-6532(03)00120-3 – ident: e_1_2_1_13_1 doi: 10.1128/CMR.15.3.485-505.2002 – ident: e_1_2_1_4_1 doi: 10.1016/S0735-1097(03)00648-X – ident: e_1_2_1_36_1 doi: 10.1002/art.11038 – ident: e_1_2_1_37_1 doi: 10.1182/blood-2003-05-1522 – ident: e_1_2_1_7_1 doi: 10.1128/jvi.60.2.548-557.1986 – ident: e_1_2_1_21_1 doi: 10.1161/01.CIR.0000155616.07901.35 – ident: e_1_2_1_5_1 doi: 10.1053/hupa.2003.48 – ident: e_1_2_1_26_1 doi: 10.1073/pnas.0602259103 – ident: e_1_2_1_34_1 doi: 10.1002/jmv.1890390413 – ident: e_1_2_1_39_1 doi: 10.1016/j.virol.2003.09.011 – ident: e_1_2_1_3_1 doi: 10.1128/JVI.79.22.14197-14206.2005 – ident: e_1_2_1_38_1 doi: 10.1016/S1534-5807(01)00031-4 – ident: e_1_2_1_29_1 doi: 10.1161/01.CIR.99.10.1348 – ident: e_1_2_1_11_1 doi: 10.1161/01.CIR.0000048147.15962.31 |
| SSID | ssj0008922 |
| Score | 2.1512604 |
| Snippet | Parvovirus B19 (PVB19) is a member of the human erythrovirus family detected frequently in endomyocardial biopsies from patients with dilated cardiomyopathy.... |
| SourceID | proquest pubmed pascalfrancis crossref wiley istex fao |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 1243 |
| SubjectTerms | Adult Aged Amino Acid Sequence Base Sequence Biological and medical sciences Capsid Proteins - chemistry Cardiomyopathy, Dilated - virology dilated cardiomyopathy Epidemiology Erythrovirus Erythrovirus - genetics Erythrovirus - isolation & purification Female Fundamental and applied biological sciences. Psychology Genotype genotypes Heart - virology heart failure Human viral diseases Humans Infectious diseases Male Medical sciences Microbiology Middle Aged Miscellaneous Molecular Sequence Data Parvoviridae Infections - virology Parvovirus B19 Prevalence Sequence Alignment Viral diseases Viral Load Virology |
| Title | Prevalence of erythrovirus genotypes in the myocardium of patients with dilated cardiomyopathy |
| URI | https://api.istex.fr/ark:/67375/WNG-79NVRKT5-F/fulltext.pdf https://onlinelibrary.wiley.com/doi/abs/10.1002%2Fjmv.21187 https://www.ncbi.nlm.nih.gov/pubmed/18461615 https://www.proquest.com/docview/20301415 https://www.proquest.com/docview/47655463 https://www.proquest.com/docview/69202995 |
| Volume | 80 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF6VHhAX3tDwKCuEEBenzj78ECcEhKooOZSm9IBYrfdRhTY2iuOK8OuZsWNHQY2EONmHWVs7O7vz7c7sN4S8ErHOwLPbIARfFwhwYUEaDVxgNZfWpmEmGN4dHo2jw4k4OpNnO-Rtexem4YfoDtxwZtTrNU5wnZUHa9LQH7OrPsNi2bD-DniEvPkfjtfUUUnaRBBgJQjAB8mWVShkB13LDV90w-sCECoq9xdmSOoSlOSb6hbXwc9NNFu7o-Ed8q3tSJOFctGvFlnf_P6L4_E_e3qX3F7BVPqusat7ZMfl98nN0SoQ_4B8R-onXV9YooWnbr7EegtX03lVUqR9xZPdkk5zCviSzpbgMMEQqxnKrphcS4pHwNROLwHtWloLFCCJJZKXD8lk-PHk_WGwKtUQGBHHcRAxZmBYeZRKnSTOG54kEh7eMB9JH3onvICdTmSkGQhjYJsWizDjjnHHLc_4I7KbF7nbIzSz3sdJZgFbpMImJtWpjgeCOW6YTbzvkTftoCmz4jHHchqXqmFgZgr0pWp99cjLTvRnQ95xndAejLzS57CoqskXhqFcsJ4IXHePvK7NoWus5xeYCBdL9XX8ScXp-PT484lUwx7Z37CXrgGGeQEAwU9etAakYP5iUEbnrqhKlMBcW7ldQsQRphLy7RJRykKAFfCNx41trnsL8BIxPSittrDtalBHo9P65cm_iz4lt5r0GcxefkZ2F_PKPQeMtsj268n4B1yxNsM |
| linkProvider | Wiley-Blackwell |
| linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LbxMxELbaIgGX8qbh0VoIIS6bbrzel8QFIUJomxxKUnoBy-sHStvsomy2Ivx6ZvYVBTUS4rR7GO_K47Hns2f8DSGveSgT8OzaccHXORxcmBMHPeNo6flax27CGd4dHo6CwYQfnfvnW-Rdcxem4odoD9xwZpTrNU5wPJA-XLGGXsyuuwyrZW-TW2V8DiHR6Yo8KoqrGAKsBQ54Ib_hFXLZYdt0zRttW5kBRkX1_sIcSZmDmmxV3-ImALqOZ0uH1L9HvjVdqfJQLrvFIumq33-xPP5vX--T3Rqp0veVaT0gWyZ9SG4P61j8I_Id2Z9keWeJZpaa-RJLLlxP50VOkfkVD3dzOk0pQEw6W4LPBFssZihbk7nmFE-BqZ5eAeDVtBTIQBKrJC8fk0n_4_jDwKmrNTiKh2HoBIwpGFkviH0ZRcYqL4p8eFjFbOBb1xpuOWx2AuWrHlcKdmohdxPPMM942ku8J2QnzVKzR2iirQ2jRAO8iLmOVCxjGfY4M55iOrK2Q942oyZUTWWOFTWuREXCzAToS5T66pBXrejPir_jJqE9GHohf8C6KiZfGEZzwXwC8N4d8qa0h7axnF9iLlzoi6-jTyKMR2enx2Nf9Dtkf81g2gYY6QUMBD85aCxIwBTGuIxMTVbkKIHptv5mCR4GmE3obZYIYuYCsoBvPK2Mc9VbQJgI60FppYltVoM4Gp6VL8_-XfSA3BmMhyfi5PPo-Dm5W2XTYDLzC7KzmBfmJUC2RbJfzsw_rNk64Q |
| linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1LbxMxELbaIlVceEPDo7UQQlw23djelzghIJSWRKg0pQeE5fUDhTa7VZKtCL-emX1FQY2EOO0exrvyeOz57Bl_Q8gLEakUPLvxfPB1ngAX5iVhz3pG8cCYxE8Fw7vDg2F4MBKHZ8HZBnnd3IWp-CHaAzecGeV6jRP80rj9JWnoz8lVl2Gx7E1yQ4TgJhERHS-5o-KkCiHAUuCBEwoaWiGf7bdNV5zRplM5QFTU7i9MkVQz0JKryltchz9X4Wzpj_q3ybemJ1Uaynm3mKdd_fsvksf_7OodcqvGqfRNZVh3yYbN7pHtQR2Jv0--I_eTKm8s0dxRO11gwYWr8bSYUeR9xaPdGR1nFAAmnSzAY4IlFhOUralcZxTPgKkZXwDcNbQUyEESayQvHpBR__3J2wOvrtXgaRFFkRcypmFceZgEKo6t0zyOA3g4zVwYON9Z4QRsdUId6J7QGvZpkfBTbhm33PCUPyRbWZ7ZHUJT41wUpwbARSJMrBOVqKgnmOWamdi5DnnVDJrUNZE51tO4kBUFM5OgL1nqq0Oet6KXFXvHdUI7MPJS_YBVVY6-MIzlgvWE4Ls75GVpDm1jNT3HTLgokF-HH2SUDE-Pj04C2e-Q3RV7aRtgnBcQEPxkrzEgCRMYozIqs3kxQwlMtg3WS4goxFxCvl4iTJgPuAK-8aiyzWVvAV8iqAellRa2Xg3ycHBavjz-d9E9sv35XV9--jg8ekJuVqk0mMn8lGzNp4V9Bnhtnu6W8_IP0qY5kA |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Prevalence+of+erythrovirus+genotypes+in+the+myocardium+of+patients+with+dilated+cardiomyopathy&rft.jtitle=Journal+of+medical+virology&rft.au=K%C3%BChl%2C+U.&rft.au=Lassner%2C+D.&rft.au=Pauschinger%2C+M.&rft.au=Gross%2C+U.M.&rft.date=2008-07-01&rft.issn=0146-6615&rft.eissn=1096-9071&rft.volume=80&rft.issue=7&rft.spage=1243&rft.epage=1251&rft_id=info:doi/10.1002%2Fjmv.21187&rft.externalDBID=n%2Fa&rft.externalDocID=10_1002_jmv_21187 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0146-6615&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0146-6615&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0146-6615&client=summon |